1.
Avelumab for advanced Merkel cell carcinoma in the Netherlands: A nationwide survey
105P Real-world systemic treatment choices and survival outcomes of patients diagnosed with non-metastatic high-risk HR+/HER2- breast cancer in the Netherlands